Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention

J Comp Eff Res. 2018 Apr;7(4):331-341. doi: 10.2217/cer-2017-0052. Epub 2017 Nov 9.

Abstract

Aim: To assess the relationship between type of contrast media (CM), iso-osmolar contrast media (IOCM) or low-osmolar contrast media (LOCM), and major adverse renal and cardiovascular events (MARCE).

Materials & methods: Coronary or peripheral angioplasty visits were stratified into CM cohorts: IOCM or LOCM. Multivariable regression analysis used hospital fixed effects to assess the relationship between MARCE events and type of CM.

Results: Among 333,533 visits (357 hospitals), the incidence of MARCE was 7.41%. After controlling for observable and unobservable time invariant within-hospital characteristics, administration of IOCM versus LOCM was associated with a 0.69% absolute and 9.32% relative risk reduction in MARCE rate.

Conclusion: Our study indicates that as compared with LOCM, IOCM may be associated with reduction of MARCE events in coronary or peripheral angioplasty patients.

Keywords: angioplasty; low-osmolar contrast media; major adverse renal and cardiovascular events (MARCE); relative risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cardiovascular System / drug effects*
  • Comorbidity
  • Contrast Media / adverse effects*
  • Databases, Factual
  • Female
  • Humans
  • Incidence
  • Kidney / drug effects*
  • Male
  • Middle Aged
  • Models, Statistical
  • Osmolar Concentration
  • Risk
  • Triiodobenzoic Acids

Substances

  • Contrast Media
  • Triiodobenzoic Acids